| ? |
B6;129-Bnip1tm1/Rbrc
|
|
|
mutant stock
|
RBRC
|
17
|
Bnip1tm1
|
targeted mutation 1
|
BCL2/adenovirus E1B interacting protein 1
|
targeted mutation
|
| ? |
B6;129-Bnip1tm2/Rbrc
|
|
|
mutant stock
|
RBRC
|
17
|
Bnip1tm2
|
targeted mutation 2
|
BCL2/adenovirus E1B interacting protein 1
|
targeted mutation
|
| ? |
B6;129S4(Cg)-Bnip1tm1.1/Rbrc
|
|
|
mutant stock
|
RBRC
|
17
|
Bnip1tm1.1
|
targeted mutation 1.1
|
BCL2/adenovirus E1B interacting protein 1
|
targeted mutation
|
| ? |
B6;129S4(Cg)-Bnip1tm1.2/Rbrc
|
|
|
mutant stock
|
RBRC
|
17
|
Bnip1tm1.2
|
targeted mutation 1.2
|
BCL2/adenovirus E1B interacting protein 1
|
targeted mutation
|
| ? |
Bnip1tm1a(KOMP)Wtsi
|
|
|
mutant strain
|
KOMP
|
17
|
Bnip1tm1a(KOMP)Wtsi
|
targeted mutation 1a, Wellcome Trust Sanger Institute
|
BCL2/adenovirus E1B interacting protein 1
|
targeted mutation
|